Q2 2026 results exceeded revenue and adjusted EBITDA guidance, driven by strong execution and the Vitalware divestiture, which enabled full debt repayment and a debt-free balance sheet. Updated 2026 guidance reflects the removal of Vitalware, ongoing migration costs, and continued investment in core technology and talent.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.